Latest Tourism News

EVT Limited has officially kicked off the sale process for its prime Sydney CBD property at 525 George Street, offering a rare mixed-use development opportunity with significant growth potential.

Reef Casino Trust reported stable 2024 financial results with steady distributions, while confidential takeover proposals from two groups are under board review. Operational challenges include rising regulatory costs and inflationary pressures.

Experience Co Limited reported a resilient 10% growth in underlying EBITDA for Q3 FY25, overcoming significant weather disruptions that impacted its Adventure Experiences segment. Skydiving operations, particularly in New Zealand, drove the positive momentum, while April trading showed all units profitable.

Kelsian Group signals a cautious FY25 outlook with EBITDA tracking at the lower end of guidance, while advancing strategic tourism divestments and securing key contract renewals.

Rare Foods Australia has secured shareholder approval to voluntarily delist from the ASX, while implementing significant cost reductions and achieving record growth in its Subsea Estate wine brand.

Tungsten Mining NL has made significant strides in developing its Mt Mulgine and Hatches Creek projects, with a maiden Mineral Resource Estimate for Hatches Creek expected soon and key environmental approvals progressing.

Lark Distilling Co. reported a robust Q3FY25 with net sales rising 31% to $4.3 million, driven by growth in travel retail, ecommerce, and exclusive whisky releases. The company also progressed its Pontville distillery redevelopment and maintained positive operating cash flow.

Pancontinental Energy reports a significant 3.8 billion barrels of net prospective oil resources at its Saturn Complex in Namibia’s PEL 87, advancing farmout talks and environmental approvals for exploration drilling.

Chilwa Minerals advances its critical minerals exploration with over 3,000 metres drilled at key deposits, a strategic assay lab shift to South Africa, and expanded local lab operations to support growing activity.

ReNerve Limited reported a 39% sales increase in Q3 FY25 alongside compelling clinical validation of its NervAlign® Nerve Cuff and strategic international partnerships, positioning the company for broader market penetration.

Donaco International reported a modest revenue and EBITDA decline in Q3 FY2025 but strengthened its cash reserves. Meanwhile, the company agreed to a full acquisition scheme at a significant premium, setting the stage for shareholder decisions amid regulatory uncertainties.

Blue Energy Limited reports steady progress in its Sapphire Pilot gas production despite operational interruptions and ongoing environmental authority appeals, while advancing seismic exploration in the Northern Territory.